SGLT2 Inhibitors: Benefits for CKD and Cardiovascular Disease in Type 2 Diabetes

被引：0
|
作者：
Rohit Singhal
Lisa Aimee Hechanova
机构：
[1] Texas Tech University Health Science Center El Paso,
来源：
Current Cardiology Reports | 2022年 / 24卷
关键词：
SGLT2 inhibitors; SGLT2; Diabetes mellitus; Renal protection; Cardiovascular risk; Heart failure prevention;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：183 / 189
页数：6
相关论文
共 50 条
  • [1] SGLT2 Inhibitors: Benefits for CKD and Cardiovascular Disease in Type 2 Diabetes
    Singhal, Rohit
    Hechanova, Lisa Aimee
    CURRENT CARDIOLOGY REPORTS, 2022, 24 (03) : 183 - 189
  • [2] SGLT2 inhibitors in diabetes with CKD
    Malik, A. H.
    Yandrapalli, S.
    Goldberg, M.
    Jain, D.
    Frishman, W. H.
    Aronow, W. S.
    EUROPEAN HEART JOURNAL, 2019, 40 : 1448 - 1448
  • [3] Maximize Benefits of SGLT2 Inhibitors in People with Advanced CKD Stages with Type 2 Diabetes
    Kashima, Koji
    Shimizu, Hiroyuki
    Yamada, Masanobu
    DIABETES, 2022, 71
  • [4] SGLT2 inhibitors with cardiovascular benefits: Transforming clinical care in Type 2 diabetes mellitus
    d'Emden, Michael
    Amerena, John
    Deed, Gary
    Pollock, Carol
    Cooper, Mark E.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2018, 136 : 23 - 31
  • [5] SGLT2 inhibitors for patients with type 2 diabetes and CKD: a narrative review
    Thomas, Merlin C.
    Neuen, Brendon L.
    Twigg, Stephen M.
    Cooper, Mark E.
    Badve, Sunil, V
    ENDOCRINE CONNECTIONS, 2023, 12 (08)
  • [6] Optimising the Benefits of SGLT2 Inhibitors for Type 1 Diabetes
    Evans, Marc
    Hicks, Debbie
    Patel, Dipesh
    Patel, Vinod
    McEwan, Phil
    Dashora, Umesh
    DIABETES THERAPY, 2020, 11 (01) : 37 - 52
  • [7] Optimising the Benefits of SGLT2 Inhibitors for Type 1 Diabetes
    Marc Evans
    Debbie Hicks
    Dipesh Patel
    Vinod Patel
    Phil McEwan
    Umesh Dashora
    Diabetes Therapy, 2020, 11 : 37 - 52
  • [8] Investigating Cardiovascular Benefits of SGLT2 Inhibitors
    Sieracki, Lauren
    Sordi, Christina
    Ostroff, Marissa L.
    Ostroff, Jared L.
    US PHARMACIST, 2022, 47 (11) : 17 - 22
  • [9] A review of cardiovascular benefits of SGLT2 inhibitors
    Zhang, Yingxia
    Han, Qinghua
    MEDICINE, 2022, 101 (36) : E30310
  • [10] SGLT2 inhibitors: providing cardiovascular protection in type 2 diabetes?
    Wilding, John
    LANCET DIABETES & ENDOCRINOLOGY, 2016, 4 (05): : 379 - 381
12345